These authors reported that the SMN2 copy number affects the survival time of patients with ALS (median survival: 0 copies, 34 months; 1 copy, 39 months; 2 copies, 44 months; 3 copies, 54 months; log-rank test, p < 0.05). Here, SMN2 is linked to amyotrophic lateral sclerosis.